House E&C Releases Recommendations To Revamp 340B

The House Energy & Commerce Committee released a report Wednesday (Jan. 10) with several recommended changes to the 340B drug discount program -- including giving the Health Resources and Services Administration more authority, resources and staff; requiring more audits of manufacturers and providers; and clarifying the intent of the 340B program. "Congress did not clearly identify the intent of the program and did not identify clear parameters, leaving the statute silent on many important program requirements," the report says, noting...